Highest-materiality recent filing
Wyndham CEO Ballotti diagnosed with multiple myeloma; CAO Rossi to depart, Androski to succeed
CEO Geoff Ballotti diagnosed with multiple myeloma (treatable bone cancer); prognosis favorable, treatment at Dana-Farber; he plans to continue working largely as normal with reduced travel.
Wyndham Q1 adjusted EPS up 12% to $0.96; rooms up 4%, pipeline record 2,200 hotels
Net income flat at $61M; adjusted net income +9% to $73M; diluted EPS $0.80 (+3%); adjusted diluted EPS $0.96 (+12%).
Wyndham issues $650M 5.625% senior notes due 2033 to repay credit facility debt
Issued $650M aggregate principal of 5.625% senior notes due March 1, 2033; interest paid semi-annually.
Wyndham Hotels Reports Q4 & Full-Year 2025 Results, Increases Dividend 5%, Provides 2026 Outlook
Full-year 2025 adjusted diluted EPS rose 6% to $4.58, adjusted EBITDA grew 3% to $718M, in line with expectations.
Wyndham Hotels CFO Michele Allen departs; Kurt Albert named Interim CFO
Michele Allen steps down as CFO and Head of Strategy effective Nov 4, 2025, to pursue external opportunity.
Wyndham Q3 adj EPS up 5% but fee revenue down 3%; lowers FY25 guidance
Q3 net income $105M (+3% YoY); adj diluted EPS $1.46 (+5% YoY); fee-related revenue $382M (-3% YoY).
Wyndham Q2 adjusted EPS $1.33 beats, raises FY2025 EPS outlook, pipeline record 255k rooms
Q2 2025 adjusted diluted EPS $1.33 (+18% YoY or +11% comparable basis); GAAP diluted EPS $1.13 (+6%).
On July 31, 2026 (the “Effective Date”), Nicola Rossi, Chief Accounting Officer of Wyndham Hotels & Resorts, Inc. (the “Company”), will depart from the Company.
As of the Effective Date, Christopher Androski, age 52, who is currently the Company’s Senior Vice President and Controller, will assume the role of Chief Accounting Officer.
Max materiality 0.90 · Median 0.62 · Most common event leadership